stockrowInterparfums, Inc.
IPAR Consumer Defensive Household & Personal Products
Interparfums, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.49% from fiscal 2024.
- Revenue
- −0.02%
- EPS
- +3.90%
- Free cash flow
- −6.15%
- Total debt
- −28.5%
Quarter to September 2026, against a year earlier
Follow IPAR
Alert me
Interparfums, Inc. (IPAR) EPS (diluted)
Interparfums, Inc.'s EPS (diluted) for fiscal 2025 was $5.24, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $5.31. Over the past ten years it has ranged from $0.98 (fiscal 2015) to $5.24 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 5 consecutive fiscal years. Interparfums, Inc. ranks 4th of 25 Household & Personal Products companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $5.24 | 2.34% |
| FY2024 | $5.12 | 7.79% |
| FY2023 | $4.75 | 25.66% |
| FY2022 | $3.78 | 37.45% |
| FY2021 | $2.75 | 127.27% |
| FY2020 | $1.21 | (36.32%) |
| FY2019 | $1.90 | 11.11% |
| FY2018 | $1.71 | 28.57% |
| FY2017 | $1.33 | 24.30% |
| FY2016 | $1.07 | 9.18% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $2.13 | 124.21% |
| Jun 2026 | $0.95 | (29.63%) |
| Mar 2026 | $1.35 | 53.41% |
| Dec 2025 | $0.88 | (57.07%) |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CLX The Clorox Company compare | $5.59 |
| IPAR Interparfums, Inc. | $5.31 |
| SPB Spectrum Brands Holdings Inc. compare | $3.28 |
| ELF e.l.f. Beauty compare | $1.45 |
| ODD ODDITY Tech Ltd. compare | $0.24 |
| COTY Coty compare | −$0.65 |
| NWL Newell Brands Inc. compare | −$0.77 |
| EPC Edgewell Personal Care Company compare | −$2.00 |
| HELE Helen of Troy Limited compare | −$4.36 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on IPAR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement